In February 2018, Abbott Laboratories announced a partnership with Insulet Corporation. Abbott integrates the next-generation Continuous Glucose Monitoring (CGM) technology with the Omnipod Horizon Automated Insulin Delivery System from Insulet. This partnership would result in streamlined, personalized diabetes care for insulin users. Glucose data from our FreeStyle Libre next-generation sensor will be sent directly to the Omnipod Horizon pod to regulate insulin delivery automatically.
Read More@: https://www.emergenresearch.com/industry-report/drug-infusion-systems-market
Some Key Highlights From the Report
The open-loop system segment revenue is expected to expand at a significant CAGR during the forecast period. Increasing usage of drug infusion systems with the open-loop system across hospitals is expected to boost revenue growth of this segment going ahead.
The continuous infusion segment is expected to lead in terms of revenue over the forecast period due to increasing usage of continuous infusion type-based drug infusion systems among end-users.
The intravenous segment is expected to lead in terms of revenue over the forecast period due to increasing usage of intravenous route for insulin delivery to insulin-dependent diabetic patients.
The diabetes segment is expected to lead in terms of revenue over the forecast period due to increasing application of drug infusion systems for insulin delivery to diabetics.
Factors such as rising prevalence of chronic diseases and increasing adoption of technologically advanced medical equipment in the healthcare industry in countries in North America is expected to drive growth of the market in the region during the forecast period.
Key players in the market include Medtronic plc, Arcomed Ag, Baxter International Inc., Insulet Corporation, Smiths Group plc, Becton, Dickinson and Company, Halyard Health, Inc., ICU Medical, Inc., Flowonix Medical Inc., and Zyno Medical LLC
Emergen Research has segmented the global drug infusion systems market on the basis of control systems, infusion type, administration route, application, end-use, and region:
Control Systems Outlook (Revenue, USD Billion; 2018–2028)
Open Loop System
Closed Loop System
Infusion Type Outlook (Revenue, USD Billion; 2018–2028)
Continuous Infusion
Intermittent Infusion
Patient Controlled Infusion
Total Parenteral Nutrition
Administration Route Outlook (Revenue, USD Billion; 2018–2028)
Enteral
Subcutaneous
Intravenous
Arterial
Epidural
Application Outlook (Revenue, USD Billion; 2018–2028)
Pediatrics
Diabetes
Nutrition
Hematology
Analgesia
Chemotherapy
Others
End-Use Outlook (Revenue, USD Billion; 2018–2028)
Diagnostic Centers
Hospitals
Ambulatory Surgical Centers
Others
Regional Outlook: (Revenue, USD Billion; 2018-2028)
North America (U.S.) (Canada) (Mexico)
Europe (Germany) (UK) (France) (BENELUX) (Rest of Europe)
Asia Pacific (China) (Japan) (South Korea) (Rest of APAC)
Latin America (Brazil) (Rest of LATAM)
Request For a FREE Sample Report@: https://www.emergenresearch.com/request-sample/692
Table of Content
Chapter 1. Methodology Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2021–2028
Chapter 3. Key Insights
Chapter 4. Drug Infusion Systems Market Segmentation Impact Analysis
4.1. Drug Infusion Systems Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing demand for safe and precise drug delivery systems
4.2.2.2. Increasing application of drug infusion system for chronic pain management
4.2.2.3. Increasing prevalence of diabetes globally
4.2.2.4. Rising demand for drug infusion system to control hemodynamics
4.2.3. Market restraints analysis
4.2.3.1. High cost of drug infusion system
4.2.3.2. Lack of skilled healthcare professional to operate drug infusion systems
4.2.3.3. Stringent government regulations for product approval
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Continue…
Related Reports.
Wi-Fi 6 Devices Market Size Worth USD 27.42 Billion in 2028
Gaming Console Market Size Worth USD 54.21 Billion in 2028
Smart Greenhouse Market Size Worth USD 3.16 Billion in 2028
Horticulture Lighting Market Size Worth USD 11.27 Billion in 2028
Smart Dust Market Size Worth USD 900.1 Million in 2028
Radiofrequency-Based Devices Market Size Worth USD 9,595.9 Million in 2028
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release@: https://www.emergenresearch.com/press-release/global-drug-infusion-systems-market
